Ketogenic diet and beta-hydroxybutyrate modulate the hepatic expression of AKT/PI3K/mTOR pathway during treatment of obesity in rats.

Journal of the Medical Research Institute Pub Date : 2024-04-01 DOI:10.21608/jmalexu.2024.279483.1014

Walaa Salim, Maher Kamel, Madiha Helmy, Nesma A Ghazal

引用次数: 0

Abstract

Ketogenic diet and beta-hydroxybutyrate modulate the hepatic expression of AKT/PI3K/mTOR pathway during treatment of obesity in rats

查看原文本刊更多论文

生酮饮食和β-羟丁酸在大鼠肥胖症治疗过程中调节肝脏AKT/PI3K/mTOR通路的表达。

生酮饮食和β-羟丁酸在大鼠肥胖症治疗过程中调节肝脏AKT/PI3K/mTOR通路的表达

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

自引率

0.00%

发文量